FIGURE

Fig. 2

ID

ZDB-FIG-250821-20

Publication

Bentanachs et al., 2025 - Telmisartan Reverses Hepatic Steatosis via PCK1 Upregulation: A Novel PPAR-independent Mechanism in Experimental Models of MASLD

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Treatment with PemA, Tel and their combination reduces the NAFLD activity score (NAS). Representative images of Oil Red O (A), Hematoxylin-Eosin (B) and Sirius Red (C) stained sections of liver samples, along with the corresponding histological analysis of CT, HFHFr, PemA, Tel and P + T groups. (D) shows NAFLD activity score, and (E) the subcomponent scores. Serum levels of AST (F), ALT (G), and (H) relative mRNA levels of markers of inflammation/oxidative stress and fibrosis. Absolute (I) and relative (J) liver weight. Hepatic content of cholesterol (K) and TG (L). Quantitative results are presented as bar plots with individual values, showing the mean ± SD of 6–8 animals/group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.